169329 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
USE OF BIOMARKER IN THE PREPARATION OF KIT USED IN METHOD FOR EARLY WARNING OF PROGNOSIS RISK IN PATIENT WITH ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
#2SEMI-QUANTITATIVE LATERAL FLOW DEVICE AND METHOD FOR DETECTING BIOMARKERS IN UNPROCESSED SALIVA
#3Mesothelin-Binding Theranostic Fibronectin Type III Tenth Domain (Fn3) Compounds
#4SYSTEM AND METHOD
#5PLASMA THERMOGRAMS FOR DIAGNOSIS AND TREATMENT OF ACUTE MYOCARDIAL INFARCTION
#6ASSAYS FOR DETECTION AND QUANTITATION OF HUMAN ENDOTROPHIN
#7CHEMILUMINESCENCE-BASED DUAL FLOW RAPID DIAGNOSTIC TESTING PLATFORM AND METHODS OF USE
#8MARKERS USEFUL IN ENRICHMENT STRATEGIES FOR THE TREATMENT OF OSTEOARTHRITIS
#9ELECTROCHEMICAL REGENERATION OF IMMUNOSENSORS
#10TREATMENT AND METHOD FOR PREDICTING DISEASE INCIDENCE, PROGRESSION, AND PROGNOSIS OF GLIOMA
#11COLLAGEN-RICH ORGANIC COMPOSITION AND PRODUCTION METHOD THEREOF
#12EXTRACELLULAR VESICLES AS BIOMARKERS AND THERAPEUTICS FOR NEUROMUSCULAR DISORDERS
#13Skeletal Muscle-On-A-Chip In Microgravity As A Platform For Regeneration Modeling And Drug Screening
#14Type XIX Collagen Assay
#15ANTI-ELASTIN ANTIBODIES AND METHODS OF USE
#16TROPNIN MARKER COMBINATIONS FOR EARLY DISCRIMINATION OF TYPE 2 VERSUS TYPE 1 ACUTE MYOCARDIAL INFARCTION
#17DETERMINING AN AMOUNT OF ANALYTE IN PLASMA BASED ON A MEASUREMENT OF AN AMOUNT OF ANALYTE IN A WHOLE-BLOOD SAMPLE
#18METHOD RELATING TO MYOSTATIN PATHWAY INHIBITION
#19METHODS FOR THE DETECTION AND QUANTIFICATION OF CIRCULATING ENDOTHELIAL CELLS
#20METHODS RELATING TO IMPAIRED RESPIRATORY HEALTH THERAPEUTICS
#21Cardiac troponin I specific antibody, kit and uses thereof
#22REDUCING THE RISK OF MAJOR ADVERSE CARDIAC EVENTS
#23REDUCING THE RISK OF MAJOR ADVERSE CARDIAC EVENTS
#24LATERAL FLOW ASSAY TEST STRIPS AND SYSTEMS, AND METHODS OF USE THEREOF
#25Nanotechnology-enabled, printable biosensors for diseases detection and method of producing thereof
#26METHODS USING TRAINED CLASSIFIER TO DISTINGUISH BETWEEN HEALTHY AND DISEASED MYOTUBES
#27METHODS FOR PREDICTING THE USEFULNESS OF PROTEINS OR PROTEIN FRAGMENTS FOR IMMUNOTHERAPY
#28METHOD OF DETERMINING LIPOPROTEIN CONCENTRATION IN SOLUTION USING LIGHT SCATTERING
#29ASSAY FOR LONG FORMS OF CARDIAC TROPONIN T
#30ORAL MESENCHYMAL STEM CELLS AND USE THEREOF
#31IMMUNOASSAY METHOD FOR CROSS-LINKED N-TELOPEPTIDE OF TYPE I COLLAGEN, IMMUNOASSAY KIT, AND ANTIBODY OR ANTIBODY FRAGMENT THEREOF
#32AFFINITY CAPTURE OF EXTRACELLULAR MATRIX BODIES
#33IMMUNOLOGICAL DETECTION METHOD AND IMMUNOLOGICAL DETECTION KIT
#34METHODS, SYSTEMS AND DEVICES FOR ASSESSING WOUND HEALING
#35RECOMBINANT ANTIBODY OF ANTI-HUMAN CARDIAC TROPONIN I
#36METHOD FOR DIAGNOSING COLLAGEN DEGRADATION ASSOCIATED DISEASE
#37IMMUNOLOGICAL DETECTION METHOD AND IMMUNOLOGICAL DETECTION KIT
#38METHODS FOR USING EXOSOMES TO MONITOR TRANSPLANTED ORGAN STATUS
#39Anastellin Biomarker
#40Anastellin Biomarker
#41LOCKED APTAMER HAIRPIN INTEGRATED HYBRIDIZATION CHAIN REACTION FOR RAPID, INSTRUMENT-FREE BIOMARKER DETECTION
#42TREATMENT OF INCLUSION BODY MYOSITIS WITH ADIPOSE-DERIVED REGENERATIVE CELLS
#43Method for Detecting Cancer in a Patient
#44COLLAGEN TYPE VII ALPHA 1 ASSAY
#45ANTIBODIES AND METHODS OF USING THEREOF
#46METHODS AND COMPOSITIONS COMPRISING ACTIN BINDING PROTEINS
#47DIAGNOSTIC BIOMARKERS FOR LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 2H AND USE THEREOF
#48Combined Immunoassay and Magnetic Immunoassay Methods for Extended Range of Sensitivity
#49GENERATING ATRIAL AND VENTRICULAR CARDIOMYOCYTE LINEAGES FROM HUMAN PLURIPOTENT STEM CELLS
#50DIAGNOSTIC ASSAY REAGENTS COMPRISING BLOCK CO-POLYMERS
#51Proteomic Risk Score For Osteoarthritis (OA)
#52CD8A-Binding Fibronectin Type III Domains
#53ASSAY FOR SARS-CoV-2 INFECTION OF VULNERABLE HUMAN CELLS
#54Renal Insufficiency Prediction and Uses Thereof
#55CARTILAGE MODEL AS A SUBSTITUTE FOR ANIMAL MODELS AND METHODS FOR EVALUATING EFFECTIVENESS OR TOXICITY OF DRUGS USING THE SAME
#56PRETREATMENT METHOD FOR QUANTITATIVE DETECTION OF UNDENATURED TYPE II COLLAGEN IN COLLAGEN PRODUCT OR CARTILAGE, AND APPLICATION
#57NOVEL LIPOCALIN MUTEINS SPECIFIC FOR CONNECTIVE TISSUE GROWTH FACTOR (CTGF)
#58IL6 MARKER PANELS FOR EARLY DETECTION OF SEPSIS
#59PLASMA THERMOGRAMS FOR DIAGNOSIS AND TREATMENT OF ACUTE MYOCARDIAL INFARCTION
#60COMPOSITIONS AND METHODS FOR DETECTING AND REGULATING FIBRONECTIN-INTEGRIN INTERACTIONS AND SIGNALING
#61Type XIX Collagen Assay
#62TARGET ANALYTE DETECTION METHOD BASED ON PROXIMITY PROTEOLYSIS REACTION
#63IMMUNOLOGICAL ANALYSIS METHOD FOR TYPE-I COLLAGEN C-TERMINAL TELOPEPTIDE
#64CARDIAC TROPONIN I SPECIFIC ANTIBODY, KIT AND USES THEREOF
#65METHODS FOR ASSAYING SLC34A2 EXPRESSION IN MUSCLE TISSUE AND TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
#66Highly Sensitive System and Method for Analysis of Troponin
#67Assay for Detecting Collagen XI Biomarkers
#68STEM CELL-DERIVED MATURE CARDIOMYOCYTES AND CARDIOVASCULAR DISEASE MODEL USING SAME
#69Addressable Microfluidics Systems and Methods for In Vivo Applications
#70DEVICE AND METHOD FOR MEASURING THE LEVEL OF BIOMARKERS AND PATHOGENS IN SUBSTANCES
#71Biomarker of Fibrosis
#72METHODS FOR MEASURING DYSTROPHIN IN TISSUE SAMPLES
#73Immunoassay controls and the use thereof
#74MODIFIED FIBROBLAST GROWTH FACTOR 21 (FGF-21) FOR USE IN METHODS FOR TREATING NONALCOHOLIC STEATOHEPATITIS (NASH)
#75IMMUNOASSAYS FOR HIGH POSITIVELY CHARGED PROTEINS
#76Type X Collagen Assays and Methods of Use Thereof
#77Quality assurance of chondrocytes
#78METHOD AND KIT OF MEASURING CONCENTRATION OF ANALYTE
#79Collagen Type XVIII Assay
#80METHOD FOR DETECTING AN ANALYTE OF INTEREST IN A SAMPLE
#81COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES AND USE THEREOF
#82METHOD RELATING TO MYOSTATIN PATHWAY INHIBITION
#83Deer-derived specific peptide and detection method therefor
#84INFLAMMATORY BIOMARKERS FOR PREDICTING RESPONSIVENESS TO FGF-18 COMPOUND
#85Assay for Assessing Heart Failure
#86METABOLIC BIOMARKERS FOR PREDICTING RESPONSIVENESS TO FGF-18 COMPOUND
#87BONE TURNOVER MARKERS ADJUSTMENT
#88COMPOSITION FOR DIAGNOSING MUSCULOSKELETAL DISEASES, COMPOSITION FOR PREVENTING OR TREATING MUSCULOSKELETAL DISEASES, AND USE THEREOF
#89SYSTEMS AND METHODS FOR DETECTION OF LAMININ BETA-1 SUBUNIT WITHIN TISSUE
#90TECHNIQUE FOR CONTROLLING QUALITY OF HUMAN PLURIPOTENT STEM CELLS USING CULTURE SUPERNATANT
#91FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY
#92Immunoassay platform for the serological discrimination of closely related viruses
#93PREVENTION AND INTERVENTION OF INFARCT EXPANSION FOLLOWING HEMORRHAGIC INFARCTIONS
#94Biomarkers for diagnosing implant related risk of implant revision due to aseptic loosening
#95FULL-LENGTH CILP AS A BIOMARKER FOR CARDIAC FIBROSIS
#96CD8A-binding fibronectin type III domains
#97METHODS FOR PREDICTING AND TREATING LAMENESS
#98MARKER AND PRODUCT FOR AUXILIARY DIAGNOSIS OF VALVULAR HEART DISEASE (VHD)
#99Probe for Specifically Detecting Pathological Collagens, and Preparation Method Therefor and Use Thereof
#100Biomarkers for diagnosing implant related risk of implant revision due to aseptic loosening
#101BAG3 AS A TARGET FOR THERAPY OF HEART FAILURE
#102Methods and Compositions for the Diagnosis of Ovarian Cancer
#103TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION
#104ANALYTE MEASUREMENT SYSTEM
#105FREEZE-DRIED PREPARATION OF CHEMILUMINESCENT IMMUNE MICROSPHERES, AND PREPARATION METHOD AND APPLICATION THEREOF
#106NOVEL METHODS FOR EARLY IDENTIFICATION OF BONE HEALING ABILITY IN INJURED PATIENTS
#107DIAGNOSIS OF AN AORTIC DISSECTION BY DETECTING A SPECIFIC BIOMARKER IN A BLOOD SAMPLE
#108METHOD FOR MEASURING COPD BIOMARKERS
#109Oligopeptide, Testing Kit Thereof And Medical Composition Thereof
#110LATERAL FLOW IMMUNOASSAY DEVICES AND METHODS OF USING SAME
#111IDENTIFICATION OF PATIENTS WITH ABNORMAL FRACTIONAL SHORTENING
#112THERANOSTICS FOR HYPERTENSION INDUCED MYOCARDIAL MICROBLEEDS
#113Three-dimensional hydrogel-graphene-based biosensor and preparation method thereof
#114PEPTIDES AND COMPOSITIONS FOR TREATMENT OF JOINT DAMAGE
#115OVARIAN CANCER BIOMARKER AND METHODS OF USING SAME
#116A SERS METHOD FOR ANALYZING A VISCOUS BIOFLUID
#117REDUCING THE RISK OF MAJOR ADVERSE CARDIAC EVENTS
#118BIOACTIVE AGENTS AND METHODS RELATED THERETO
#119COMPOSITIONS AND METHODS IDENTIFYING AND USING STEM CELL DIFFERENTIATION MARKERS
#120Methods for identifying risk of chemotherapy-induced cardiotoxicity and targeted medical intervention
#121FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY
#122Type XXIII Collagen Assay
#123DECISION TREE BASED SYSTEMS AND METHODS FOR ESTIMATING THE RISK OF ACUTE CORONARY SYNDROME
#124OSTEOMODULIN AND OSTEOMODULIN FRAGMENTS AS BIOMARKERS FOR OSTEOARTHRITIS AND USE THEREOF
#125Immunoassay for Collagen Type VIII Sequences
#126METHODS OF DETECTING SEPTIC ARTHRITIS, TRANSIENT SYNOVITIS AND OSTEOMYELITIS
#127METHODS FOR THE DETECTION AND QUANTIFICATION OF CIRCULATING ENDOTHELIAL CELLS
#128Method and system for detecting analyte of interest using magnetic field sensor and magnetic particles
#129Detection and Quantification of Molecular Species
#130Collagen Type X Alpha-1 Assay
#131Immunoassay controls and the use thereof
#132ANTI-ELASTIN ANTIBODIES AND METHODS OF USE
#133Type X Collagen Assays and Methods of Use Thereof
#134DIMERIC COLLAGEN HYBRIDIZING PEPTIDES AND METHODS OF USE THEREOF
#135MARKERS USEFUL IN ENRICHMENT STRATEGIES FOR THE TREATMENT OF OSTEOARTHRITIS
#136NEUROFILAMENT PROTEIN FOR GUIDING THERAPEUTIC INTERVENTION IN AMYOTROPHIC LATERAL SCLEROSIS
#137EXTENDED RANGE IMMUNOASSAY DEVICES WITH IMMUNOSENSOR AND MAGNETIC IMMUNOSENSOR
#138Antibody against human cardiac troponin i and use thereof
#139Antibody against human cardiac troponin I and use thereof
#140COMPOSITIONS AND METHODS FOR PREVENTION AND REDUCTION OF METASTASIS
#141DEVELOPMENT AND PARAMETER ASSESSMENT FOR VERTICALLY ALIGNED PLATINUM WIRE APTASENSOR ARRAYS FOR IMPEDIMETRIC DETECTION OF CARDIAC BIOMARKERS
#142SYNTHETIC BI-EPITOPE COMPOUND
#143Compositions and methods for detection of SMN protein in a subject and treatment of a subject
#144EXTRACELLULAR VESICLES AS BIOMARKERS AND THERAPEUTICS FOR NEUROMUSCULAR DISORDERS
#145Dimeric collagen hybridizing peptides and methods of using
#146COLLAGEN TYPE VII ALPHA 1 ASSAY
#147Metabolic biomarkers for predicting responsiveness to FGF-18 compound
#148Inflammatory biomarkers for predicting responsiveness to FGF-18 compound
#149Type X Collagen Assays and Methods of Use Thereof
#150Cardiac troponin assay method and assay reagent
#151METHODS FOR DETERMINING THE PRESENCE OR RISK OF DEVELOPING FACIOSCAPULOHUMERAL DYSTROPHY (FSHD)
#152Use of Biomarkers in the Assessment of the Early Transition from Arterial Hypertension to Heart Failure
#153Pharmaceutical composition for prevention or treatment of preterm birth
#154Combined immunoassay and magnetic immunoassay methods for extended range of sensitivity
#155Method relating to myostatin pathway inhibition
#156COLLAGEN IV BINDING ASSAY FOR THE DETECTION OF COLLAGEN VII
#157Modified fibroblast growth factor 21 (FGF-21) for use in methods for treating nonalcoholic steatohepatitis (NASH)
#158TREATMENT FOR AGE- AND OXIDATIVE STRESS-ASSOCIATED MUSCLE ATROPHY AND WEAKNESS
#159Methods to predict risk of and to stratify sarcopenia and NAD deficiency
#160Compositions and methods relating to a C-terminal peptide of troponin i with activity as a myofilament CA2+ desensitizer
#161CD8A-binding fibronectin type III domains
#162MICROFLUIDIC DEVICE, SYSTEM AND METHOD
#163BAG3 as a target for therapy of heart failure
#164MULTIVALENT MONO- OR BISPECIFIC RECOMBINANT ANTIBODIES FOR ANALYTIC PURPOSE
#165Anti-troponin T antibodies
#166Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure
#167Type X Collagen Assays and Methods of Use Thereof
#168Method of determining lipoprotein concentration in solution using light scattering
#169Quality assurance of chondrocytes
#170METHOD AND APPARATUS FOR ADMINISTERING GASES INCLUDING NITRIC OXIDE
#171Collagen Type XVI Assay
#172Using nucleic acids encoding NAP-2 polypeptides to improve cardiac function
#173Fibronectin binding domains with reduced immunogenicity
#174Highly Sensitive System and Method for Analysis of Troponin
#175Nucleic acids encoding anti-HcTNT-N69 antibodies
#176COMPOSITION COMPRISING FARNESOL AND USE THEREOF
#177LATERAL FLOW IMMUNOASSAY DEVICES AND METHODS OF USING SAME
#178RAPID TEST FOR CELLULAR FIBRONECTIN
#179Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides
#180DIAGNOSIS AND TREATMENT OF MOTILITY DISORDERS OF THE GUT AND BLADDER, AND OF FIBROMYALGIA
#181Devices and methods related to airway inflammation
#182Method for detecting analyte
#183Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
#184Methods for Identifying Risk of Chemotherapy-Induced Cardiotoxicity and Targeted Medical Intervention
#185Collagen type X alpha-1 assay
#186Image selection suggestions
#187Fibronectin binding domains with reduced immunogenicity
#188Blood biomarkers for severe traumatic brain injuries
#189Prevention of tissue ischemia and related methods
#190Peptides and compositions for treatment of joint damage
#191DUAL RANGE CARDIAC TROPONIN IMMUNOASSAY DEVICES AND METHODS USING IMMUNOSENSOR AND MAGNETIC IMMUNOSENSOR
#192METHOD FOR PROGNOSIS OF THE OUTCOME OF PATIENTS WITH HEART FAILURE (HF)
#193Methods and Compositions for the Diagnosis of Ovarian Cancer
#194PROTEOLYTIC DIGESTION OF CARDIAC TROPONIN I
#195Methods for treating or predicting risk of a ventricular tachyarrhythmia event
#196Biomarkers for diagnosing implant related risk of implant revision due to aseptic loosening
#197System and method for time-resolved fluoroimmunoassay detection
#198Circulating Angiopoietin-2 (Ang-2) for the prediction of recurrence of atrial fibrillation
#199Immunoassay controls and the use thereof
#200GENERATING ATRIAL AND VENTRICULAR CARDIOMYOCYTE LINEAGES FROM HUMAN PLURIPOTENT STEM CELLS
#201Quality assurance of chondrocytes
#202IGFBP7 for diagnosing diastolic dysfunction
#203Methods for detecting cardiac damage
#204MODULATION OF EXON RECOGNITION IN PRE-MRNA BY INTERFERING WITH THE SECONDARY RNA STRUCTURE
#205MODULATION OF EXON RECOGNITION IN PRE-MRNA BY INTERFERING WITH THE SECONDARY RNA STRUCTURE
#206Personalized healthcare P4 cardiac health and wellness monitoring system and method utilizing TMAO and troponin
#207Method of preparing an artificial tooth primordium in vitro and artificial tooth primordium derived therefrom
#208Human antibody against ED-B domain of fibronectin and uses thereof
#209Methods for predicting the usefulness of proteins or protein fragments for immunotherapy
#210Low cost disposable medical sensor fabricated on glass, paper or plastics
#211Protective Effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC Against Drugs that Cause Channelopathies
#212Marker and Method for Determining the Composition or Purity of a Cell Culture and for Determining In Vitro the Identity of a Cartilage Cell or Synovial Cell
#213Peptides and compositions for treatment of joint damage
#214Marker for Prognosis of a Clinical Outcome of an Autologous Intervertebral Disc Cell Transplantation, for Progress Assessment/Progress Monitoring of an Autologous Intervertebral Disc Cell Transplantation, for Assessing the Quality of Intervertebral Disc Cells, for Assessing the Quality of an Implant and/or Medication for Novel Therapies (ATMP) for the Treatment of an Intervertebral Disc Defect, and for Diagnosis of an Intervertebral and/or Spinal Column Defect
#215SYSTEMS AND METHODS FOR EVALUATING INTERSTITIAL FLUIDS
#216Method using slit-robo system to treat sarcopenia
#217Method of treating asthma using an IL-13 antibody
#218Microfluidic device, system and method
#219Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure
#220Method of diagnosing arthritis or other joint degrading disease
#221Method for measuring the plasma concentration of an analyte directly on a whole blood sample
#222BLOOD BIOMARKER FOR DETECTING ARTERIOSCLEROSIS
#223Osteomodulin and osteomodulin fragments as biomarkers for osteoarthritis and use thereof
#224Inflammatory Disease Treatment Composition Including Anti-Myosin Regulatory Light-Chain Polypeptide Antibody
#225Methods and compositions relating to anti-HcTnT-N69 antibody for detection of cardiac disorders
#226Method of measuring a level of anti-vinculin antibodies in a biological sample
#227Methods for reducing the risk of osteoarthritis of the knee
#228PEPTIDES WITH ANTI-ANGIOGENIC, ANTI-LYMPHANGIOGENIC, AND ANTI-EDEMIC PROPERTIES AND NANOPARTICLE FORMULATIONS
#229Systems, Methods and Computer Readable Storage Media for Analyzing a Sample
#230NTproBNP AND cTnT BASED THERAPY GUIDANCE IN HEART FAILURE
#231ENHANCED EXPRESSION OF mTOR AND INHIBITED EXPRESSION OF MYOSTATIN IN SKELETAL MUSCLE CELLS
#232Development and parameter assessment for vertically aligned platinum wire aptasensor arrays for impedimetric detection of cardiac biomarkers
#233REAGENT AND METHOD FOR MEASURING CARDIAC TROPONIN I
#234Humanized or affinity-matured anti ang-2 antibody and uses thereof
#235METHOD FOR EVALUATING ARTICULAR JOINT THERAPEUTICS
#236Type X Collagen Assays and Methods of Use Thereof
#237Multiple hybrid immunoassay
#238Method of Determining Risk of an Adverse Cardiac Event
#239Method for detecting plasminogen activator inhibitor-1 in a sample
#240Immunoassay for Collagen Type VIII Sequences
#241Methods and compositions for the diagnosis of ovarian cancer
#242System and methods for predicting drug-induced inotropic and pro-arrhythmia risk
#243SARCOMERE BIOSENSOR AND METHODS OF USE THEREOF
#244NAP-2 polypeptides and methods for modulating immune system activity in heart tissue
#245METHODS FOR USING EXOSOMES TO MONITOR TRANSPLANTED ORGAN STATUS
#246Biomarkers to improve prediction of heart failure risk
#247Assessing whether a subject shall be subjected to imaging based diagnostic
#248Troponin and BNP based diagnosis of risk patients and cause of stroke
#249Peptides and compositions for treatment of joint damage
#250Cardiovascular risk event prediction and uses thereof
#251Characterization of Type 1 Collagen Synthesis By Fluorescence Imaging and Related Drug Screening Technique
#252METHODS OF VALIDATING CANDIDATE COMPOUNDS FOR USE IN TREATING COPD AND OTHER DISEASES
#253Biomarkers for the detection of acute rejection in heart transplantation
#254Dual range cardiac troponin immunoassay devices and methods using immunosensor and magnetic immunosensor
#255Combined immunoassay and magnetic immunoassay methods for extended range of sensitivity
#256Extended range immunoassay devices with immunosensor and magnetic immunosensor
#257CD8a-binding fibronectin type III domains
#258BIOMARKER FOR CARDIAC DISORDERS
#259METHODS FOR TREATMENT OF CARDIOVASCULAR DISEASE
#260Use of molecular marker Dkk-3 associated with muscle atrophy
#261Methods for Treatment with Bucindolol Based on Genetic Targeting
#262ULTRA-SMALL APOB-CONTAINING PARTICLES AND METHODS OF USE THEREOF
#263Secreted Protein Acidic and Rich in Cysteine (SPARC) Protein SRM/MRM Assay
#264AZO-quaternary pyridinium salts with acid-enhanced antibacterial efficacy, methods of use, methods of synthesis, and uses thereof
#265Highly Sensitive System and Methods for Analysis of Troponin
#266Biomarkers for assessment of preeclampsia
#267Method for detecting anti-vinculin antibodies in a subject with an IBS symptom
#268Immunoassay for Collagen Type VI Sequence
#269Methods and apparatus for assessment of risk for joint injury
#270Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies
#271Methods for detecting cardiac damage
#272IMMUNOASSAYS FOR HIGH POSITIVELY CHARGED PROTEINS
#273Methods for early identification of bone healing ability in injured patients
#274Collagen IV binding assay for the detection of collagen VII
#275METHODS FOR QUANTITATIVE ASSESSMENT OF MUSCLE FIBERS IN MUSCULAR DYSTROPHY
#276Dimeric collagen hybridizing peptides and methods of using
#277Proteolytic digestion of cardiac troponin I
#278Methods for treating spinal muscular atrophy
#279Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#280Method for identifying a compound useful with myosin regulatory light chain polypeptide antibody for treatment of an inflammatory disease
#281Autoantigen in idiopathic inflammatory myopathies
#282Peptides and compositions for treatment of joint damage
#283Cardiac troponin I ultra-sensitive detection reagent kit, and ultra-sensitive detection method therefor
#284CARDIAC TROPONIN I DETECTION DURING PREGNANCY FOR CARDIOVASCULAR DISEASE IDENTIFICATION AND RISK ASSESSMENT
#285Method for evaluating articular joint therapeutics
#286Decision tree based systems and methods for estimating the risk of acute coronary syndrome
#287Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
#288ASSAYS FOR HUMAN NT-PRO B-TYPE NATRIURETIC PEPTIDE, HUMAN PRO B-TYPE NATRIURETIC PEPTIDE AND HUMAN B-TYPE NATRIURETIC PEPTIDE
#289Synthetic bi-epitope compound
#290Identity and purity of tissue biopsies
#291BIOMARKERS PREDICTIVE OF MUSCLE ATROPHY, METHOD AND USE
#292Method of promoting wound healing
#293Methods for predicting and treating myocardial damage
#294METHODS AND COMPOSITIONS FOR IMAGING VIA MOLECULAR BIASING
#295Highly sensitive system and method for analysis of troponin
#296Methods for treating or predicting risk of a ventricular tachyarrhythmia event
#297METHODS AND COMPOSITIONS FOR MONITORING HEART FAILURE
#298Fibronectin binding domains with reduced immunogenicity
#299REACTION METHOD, DETECTION METHOD, AND DETECTION DEVICE
#300Methods and compositions for wound treatment